Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 89 peer-reviewed journal articles Updated
Endocrinology

Nodular Goiter: A Patient Guide

At a Glance

Most nodular goiters are benign and do not need immediate treatment. Blood tests and ultrasound show how the thyroid is working and whether a nodule needs biopsy; ongoing ultrasound monitoring is common, while surgery is reserved for selected higher-risk or compressive cases.

A nodular goiter is a very common condition involving the enlargement of the thyroid gland and the development of one or more lumps, known as nodules, within its tissue [1]. For most people, finding a nodule is a discovery made by chance during an imaging test for an unrelated issue, as these growths are overwhelmingly benign and often stay small enough that they never cause symptoms [2][3]. While the word “goiter” can sound alarming, it is simply a descriptive term for an enlarged thyroid; in the majority of cases, it represents a stable condition that does not interfere with daily life [1].

The evaluation of a nodular goiter focuses on two main goals: ensuring the thyroid is functioning correctly and determining if any of the nodules require closer attention. This process begins with a biochemical screening blood test for Thyroid-Stimulating Hormone (TSH), often followed by free T4 and T3 tests, to see if the nodules are “toxic”—meaning they are overproducing hormones—or “non-toxic” and quiet [4]. This is followed by a high-resolution ultrasound, which is the most effective tool for looking at the physical structure of the nodules to determine which ones are low-risk and which may need a biopsy based on their features [5][6].

Most nodules are benign, but management depends on test results, symptoms, hormone levels, and your personal risk profile. For the vast majority of patients, treatment is not needed immediately, and “active surveillance” becomes the standard of care. This approach involves periodic ultrasounds to monitor for any significant changes in size or appearance [7]. Intervention is typically reserved for nodules that are found to be cancerous, those that are overproducing hormones and affecting the heart or metabolism, or very large goiters that physically press on the windpipe or esophagus [8][9]. Even when a biopsy result is “indeterminate”—meaning it isn’t clearly benign or malignant—modern molecular testing can help refine the risk and may help many people avoid diagnostic surgery [10][11].

Living with a nodular goiter is usually a journey of long-term monitoring rather than active illness. By combining regular medical check-ups with an understanding of how these nodules behave, you and your care team can manage the condition effectively while maintaining your overall quality of life [12]. Most people find that once their goiter is evaluated and confirmed to be benign, it becomes a manageable part of their health history that requires only occasional attention.

(Note: Recommendations can differ by country, laboratory, pregnancy status, and specialist assessment. Discuss your individual circumstances with your care team.)

In this guide

6 chapters

01

Understanding Nodular Goiter: Biology and Types

Learn how nodular goiter differs from thyroid nodules, including solitary and multinodular types, toxic versus nontoxic function, and key risk factors.

02

Symptoms and Warning Signs of Nodular Goiter

Learn the symptoms of nodular goiter, including neck pressure, swallowing trouble, hoarseness, hyperthyroidism signs, and when to seek emergency care quickly.

03

The Diagnostic Pathway for Nodular Goiter: Tests and Imaging

Learn how nodular goiter is evaluated, from TSH blood tests and thyroid ultrasound to TI-RADS, radionuclide scans, FNA, and when CT or MRI may be needed.

04

Biopsy and Molecular Testing for Thyroid Nodules

Learn what thyroid nodule biopsy results mean, including Bethesda categories, indeterminate findings, molecular testing, cancer risk, and possible surgery.

05

Treatment Strategies for Nodular Goiter

Learn about nodular goiter treatment, including surveillance, surgery, radioactive iodine, methimazole, and ablation, plus benefits, risks, and follow-up.

06

Living With and Monitoring Nodular Goiter

Learn how to live with and monitor nodular goiter, including ultrasound timing, growth triggers, symptom tracking, scan anxiety, and when to seek prompt care.

Common questions in this guide

What is a nodular goiter, and are thyroid nodules usually cancerous?
A nodular goiter is an enlarged thyroid gland with one or more lumps called nodules. Most thyroid nodules are benign, but blood tests and ultrasound help determine whether a nodule needs closer evaluation or a biopsy.
What tests are used to evaluate a nodular goiter?
A TSH blood test checks whether the thyroid is making the right amount of hormone, and free T4 or T3 tests may provide additional information. A thyroid ultrasound examines the nodule’s size and appearance, and some nodules may need a needle biopsy based on their features.
What does it mean if a thyroid nodule is toxic or non-toxic?
A toxic nodule makes too much thyroid hormone, while a non-toxic nodule does not appear to overproduce hormones. Excess hormone can affect the heart and metabolism, so a toxic nodule may need treatment rather than observation alone.
How are benign thyroid nodules monitored?
Many benign or low-risk nodules are managed with active surveillance instead of immediate treatment. This usually means having follow-up ultrasounds to check for meaningful changes in the nodule’s size or appearance, with the schedule based on your individual findings.
What happens if my thyroid biopsy is indeterminate?
An indeterminate biopsy does not clearly show whether a nodule is benign or cancerous. Molecular testing may provide more information about the nodule’s risk and help you and your clinician decide whether diagnostic surgery is necessary.
When does a nodular goiter need treatment or surgery?
Treatment is generally considered when a nodule is cancerous, produces excess thyroid hormone that affects health, or when a large goiter presses on the windpipe or esophagus. The best option depends on the test results, symptoms, hormone levels, and personal risk factors.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my TSH levels and ultrasound, do my nodules appear to be active (toxic) or quiet?
  2. 2.What features on my ultrasound are you tracking, and what would be considered a 'significant' change at my next visit?
  3. 3.If my biopsy comes back as 'indeterminate,' will we use molecular testing to help decide if surgery is necessary?
  4. 4.How does my personal risk profile, such as age or family history, change the way we approach these results?
  5. 5.Is my goiter currently causing any narrowing of my windpipe or affecting my swallowing?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.

    Knobel M

    Journal of endocrinological investigation 2016; (39(4)):357-73 doi:10.1007/s40618-015-0391-7.

    PMID: 26392367
  2. 2

    Management of thyroid nodules.

    Alexander EK, Doherty GM, Barletta JA

    The lancet. Diabetes & endocrinology 2022; (10(7)):540-548 doi:10.1016/S2213-8587(22)00139-5.

    PMID: 35752201
  3. 3

    Thyroid Ultrasound: Diffuse and Nodular Disease.

    Alexander LF, Patel NJ, Caserta MP, Robbin ML

    Radiologic clinics of North America 2020; (58(6)):1041-1057 doi:10.1016/j.rcl.2020.07.003.

    PMID: 33040847
  4. 4

    Thyroid nodules: diagnosis and management.

    Wong R, Farrell SG, Grossmann M

    The Medical journal of Australia 2018; (209(2)):92-98 doi:10.5694/mja17.01204.

    PMID: 29996756
  5. 5

    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

    Haugen BR, Alexander EK, Bible KC, et al.

    Thyroid : official journal of the American Thyroid Association 2016; (26(1)):1-133 doi:10.1089/thy.2015.0020.

    PMID: 26462967
  6. 6

    Management of Thyroid Nodules.

    Uludag M, Unlu MT, Kostek M, et al.

    Sisli Etfal Hastanesi tip bulteni 2023; (57(3)):287-304 doi:10.14744/SEMB.2023.06992.

    PMID: 37900341
  7. 7

    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.

    Gharib H, Papini E, Garber JR, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(5)):622-39 doi:10.4158/EP161208.GL.

    PMID: 27167915
  8. 8

    2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules.

    Papini E, Monpeyssen H, Frasoldati A, Hegedüs L

    European thyroid journal 2020; (9(4)):172-185 doi:10.1159/000508484.

    PMID: 32903999
  9. 9

    SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: Initial work-up for thyroid nodules.

    Do Cao C, Haissaguerre M, Lussey-Lepoutre C, et al.

    Annales d'endocrinologie 2022; (83(6)):380-388 doi:10.1016/j.ando.2022.10.009.

    PMID: 36280193
  10. 10

    Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.

    Steward DL, Carty SE, Sippel RS, et al.

    JAMA oncology 2019; (5(2)):204-212 doi:10.1001/jamaoncol.2018.4616.

    PMID: 30419129
  11. 11

    Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier.

    Ahmadi S, Kotwal A, Bikas A, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(12)):e2231-e2239 doi:10.1210/clinem/dgae112.

    PMID: 38415829
  12. 12

    Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules.

    de Koster EJ, Husson O, van Dam EWCM, et al.

    Endocrine connections 2022; (11(8)).

    PMID: 35731242

This page is for informational purposes only and does not constitute medical advice. Your clinician should interpret your thyroid tests and imaging in light of your symptoms and personal risk factors.

Get notified when new evidence is published on nodular goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.